210 related articles for article (PubMed ID: 35440149)
1.
Maslennikov R; Ivashkin V; Ufimtseva A; Poluektova E; Ulyanin A
Future Microbiol; 2022 Jun; 17():653-663. PubMed ID: 35440149
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for complicated course and recurrence of Clostridioides Difficile infections during COVID-19 pandemic.
Bednarska A; Sosińska-Bryła I; Hackiewicz M; Bursa D; Makowiecki M; Porowski D; Horban A
Przegl Epidemiol; 2022; 77(1):23-33. PubMed ID: 37283245
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19.
Laszkowska M; Kim J; Faye AS; Joelson AM; Ingram M; Truong H; Silver ER; May B; Greendyke WG; Zucker J; Lebwohl B; Hur C; Freedberg DE
Dig Dis Sci; 2021 Dec; 66(12):4398-4405. PubMed ID: 33479861
[TBL] [Abstract][Full Text] [Related]
4. Clinical Presentations, Predictive Factors, and Outcomes of Clostridioides difficile Infection among COVID-19 Hospitalized Patients—A Single Center Experience from the COVID Hospital of the University Clinical Center of Vojvodina, Serbia.
Kovačević N; Lendak D; Popović M; Plećaš Đuric A; Pete M; Petrić V; Sević S; Tomić S; Alargić J; Damjanov D; Kosjer D; Lekin M
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143939
[No Abstract] [Full Text] [Related]
5. The interplay of SARS-CoV-2 and
Khanna S; Kraft CS
Future Microbiol; 2021 Apr; 16():439-443. PubMed ID: 33847139
[TBL] [Abstract][Full Text] [Related]
6. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.
Abad CLR; Safdar N
Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444
[TBL] [Abstract][Full Text] [Related]
7. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.
Sandhu A; Tillotson G; Polistico J; Salimnia H; Cranis M; Moshos J; Cullen L; Jabbo L; Diebel L; Chopra T
Emerg Infect Dis; 2020 Sep; 26(9):2272-4. PubMed ID: 32441243
[TBL] [Abstract][Full Text] [Related]
8. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
[TBL] [Abstract][Full Text] [Related]
9. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
[TBL] [Abstract][Full Text] [Related]
10. Health care associated Clostridioides difficile infection and colonization in patients admitted at tertiary care hospital Pakistan.
Ahmed A; Ikram A; Sabir N; Zaman G; Gardeezi A; Satti L
J Pak Med Assoc; 2022 Apr; 72(4):610-615. PubMed ID: 35614587
[TBL] [Abstract][Full Text] [Related]
11. Recent development of small-molecular inhibitors against Clostridioides difficile infection.
Chen J; Lu Y; Du Y; Wang H; Wu Q
Bioorg Chem; 2022 Aug; 125():105843. PubMed ID: 35561529
[TBL] [Abstract][Full Text] [Related]
12. Predictors of hospital-onset Clostridioides difficile infection in children with antibiotic-associated diarrhea.
Polat M; Tapısız A; Demirdağ TB; Yayla BC; Kara SS; Tezer H; Belet N; Çırak MY
Am J Infect Control; 2023 Aug; 51(8):879-883. PubMed ID: 36535316
[TBL] [Abstract][Full Text] [Related]
13. Detection of Clostridioides difficile toxin B gene: benefits of identifying gastrointestinal pathogens by mPCR assay in the diagnosis of diarrhea in pediatric patients.
Byun JH; Yong D; Kim H
BMC Infect Dis; 2022 Feb; 22(1):126. PubMed ID: 35123434
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis.
Ingle M; Deshmukh A; Desai D; Abraham P; Joshi A; Rodrigues C; Mankeshwar R
Indian J Gastroenterol; 2011 Mar; 30(2):89-93. PubMed ID: 21553102
[TBL] [Abstract][Full Text] [Related]
15. Our experience with 80 cases of SARS-CoV-2-Clostridioides difficile co-infection: An observational study.
Birlutiu V; Dobritoiu ES; Lupu CD; Herteliu C; Birlutiu RM; Dragomirescu D; Vorovenci A
Medicine (Baltimore); 2022 Jul; 101(27):e29823. PubMed ID: 35801777
[TBL] [Abstract][Full Text] [Related]
16. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Hawes AM; Desai A; Patel PK
Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
[TBL] [Abstract][Full Text] [Related]
17. Is Clostridioides difficile toxins detection necessary when the glutamate dehydrogenase enzyme is detected?
García-Fuentes JF; Torres-Murillo BJ; Aguilar-Orozco G; González É; Mosqueda JL; Macías AE; Álvarez JA
Gac Med Mex; 2021; 157(1):107-109. PubMed ID: 34125803
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study.
Schechner V; Fallach N; Braun T; Temkin E; Carmeli Y
J Antimicrob Chemother; 2021 Jul; 76(8):2182-2185. PubMed ID: 33969419
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.
Maziade PJ; Ship N; Sniffen JC; Goldstein EJC
Clin Infect Dis; 2021 Oct; 73(8):1524-1527. PubMed ID: 33966076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
